A Novel Intervention for Patients With Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Novel Intervention for Patients With Cancer — Stella

Home/Substance Use/

View on ClinicalTrials.gov

Recruiting

Back to Substance Use trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Dana Farber Cancer Institute, Boston, Massachusetts

Key details

Sponsor

Dana-Farber Cancer Institute

Collaborators

National Cancer Institute (NCI)

Enrollment target

~40 participants

Started

March 2023

Primary completion

June 2026

Age range

18 Years – 99 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.